承認 against 中外製薬株式会社
中外製薬株式会社 (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareJanuary 21, 2022
Action summary
- Company
- 中外製薬株式会社Japanese onlyOriginal: 中外製薬株式会社Corporate Number: 5011501002900
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices薬機法
- Action type
- 承認承認
- Action date
- January 21, 2022
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Machine-translated summary — verify against original
Approval for the addition of indications and effects related to COVID-19 for the pharmaceutical product Actemra intravenous infusion.
Show original Japanese text
医薬品アクテムラ点滴静注用の新型コロナウイルス感染症に関する効能・効果の追加承認
Source
Original Ministry of Health, Labour and Welfare announcement (in Japanese)The original Japanese disclosure is the authoritative record.
Watch this company
Get an email when 中外製薬株式会社 has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.
Language
日本語版を見る (Japanese)Company info
- English name
- 中外製薬株式会社 Japanese only
- Japanese name
- 中外製薬株式会社
- Corporate Number
- 5011501002900
- Registered address
- 東京都北区浮間５丁目５番１号
About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.